LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the designation of Schirmer test, a measure of tear production, as the sole primary endpoint in ...
Please provide your email address to receive an email when new articles are posted on . Cyclosporine 0.05% conferred significantly higher tear breakup time compared with artificial tears. Schirmer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback